These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24509731)

  • 1. The role of a low glomerular density and being overweight in the etiology of proteinuria in CKD patients without known glomerular diseases.
    Okamoto H; Kawamura T; Okonogi H; Tsuboi N; Miyazaki Y; Yokoo T
    Clin Exp Nephrol; 2014 Dec; 18(6):911-7. PubMed ID: 24509731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.
    Tobar A; Ori Y; Benchetrit S; Milo G; Herman-Edelstein M; Zingerman B; Lev N; Gafter U; Chagnac A
    PLoS One; 2013; 8(9):e75547. PubMed ID: 24086563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological features of donor/recipient body weight mismatch after kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Nakada Y; Mafune A; Katsumata H; Furuya M; Koike K; Miki J; Yamada H; Tanno Y; Ohkido I; Tsuboi N; Yokoyama K; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():36-9. PubMed ID: 26031584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High muscle-to-fat ratio is associated with lower risk of chronic kidney disease development.
    Jhee JH; Joo YS; Han SH; Yoo TH; Kang SW; Park JT
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):726-734. PubMed ID: 32020762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological influence of obesity on renal structural changes in chronic kidney disease.
    Kato S; Nazneen A; Nakashima Y; Razzaque MS; Nishino T; Furusu A; Yorioka N; Taguchi T
    Clin Exp Nephrol; 2009 Aug; 13(4):332-340. PubMed ID: 19533267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study.
    Nishi S; Muso E; Shimizu A; Sugiyama H; Yokoyama H; Ando Y; Goto S; Fujii H
    Clin Exp Nephrol; 2017 Aug; 21(4):624-632. PubMed ID: 27562765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
    Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
    Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age.
    Koike K; Ikezumi Y; Tsuboi N; Kanzaki G; Haruhara K; Okabayashi Y; Sasaki T; Ogura M; Saitoh A; Yokoo T
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):585-590. PubMed ID: 28336816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.
    Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P
    Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibition is renoprotective among obese patients with proteinuria.
    Mallamaci F; Ruggenenti P; Perna A; Leonardis D; Tripepi R; Tripepi G; Remuzzi G; Zoccali C;
    J Am Soc Nephrol; 2011 Jun; 22(6):1122-8. PubMed ID: 21527660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England.
    Herrington WG; Smith M; Bankhead C; Matsushita K; Stevens S; Holt T; Hobbs FD; Coresh J; Woodward M
    PLoS One; 2017; 12(3):e0173515. PubMed ID: 28273171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of body mass index on progression of primary immunoglobulin a nephropathy.
    Nagaraju SP; Rangaswamy D; Mareddy AS; Prasad S; Kaza S; Shenoy S; Saraf K; Attur RP; Parthasarathy R; Kosuru S; Mateti UV; Guddattu V; Koulmane Laxminarayana SL
    Saudi J Kidney Dis Transpl; 2018; 29(2):318-325. PubMed ID: 29657199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.
    Sabanayagam C; Wong TY; Liao J; Sethi S; Teo BW
    Clin Exp Nephrol; 2014 Dec; 18(6):919-24. PubMed ID: 24526413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI, nephroangiosclerosis and glomerulonephritis: Is there any meeting point?
    Gigante A; Giannakakis K; Di Mario F; Barbano B; Rosato E; Pofi R; Di Paolo M; Rocca AR; Cianci R
    Nephrology (Carlton); 2018 Nov; 23(11):991-996. PubMed ID: 28817218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.
    Foster MC; Hwang SJ; Larson MG; Lichtman JH; Parikh NI; Vasan RS; Levy D; Fox CS
    Am J Kidney Dis; 2008 Jul; 52(1):39-48. PubMed ID: 18440684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.